# Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD)

> **NCT07751640** · PHASE1,PHASE2 · ACTIVE_NOT_RECRUITING · sponsor: **Apeiron Research Center** · enrollment: 10 (actual)

## Conditions studied

- PARKINSON DISEASE (Disorder)
- Atypical Parkinsonism

## Interventions

- **BIOLOGICAL:** Autologous Bone Marrow Aspirate (BMA) and Bone Marrow Aspirate Concentrate (BMAC)

## Key facts

- **NCT ID:** NCT07751640
- **Lead sponsor:** Apeiron Research Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2025-05-01
- **Primary completion:** 2026-09-04
- **Final completion:** 2026-09-04
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2026-08-07


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07751640

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07751640, "Autologous Bone Marrow Aspirate (IV) and Bone Marrow Concentrate (Intranasal) for Parkinson's Disease and Parkinson-Plus Syndromes (SPARC-PD)". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07751640. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*